title: [The therapeutic situation and advancement in choroidal neovascularization].
abstract: Choroidal neovascularization (CNV) caused by multi-etiological factors is one of the most common reasons of visual loss. In recent studies, photodynamic therapy is the major treatment to sub-foveal CNV, and other anti-neovascular and anti-inflammatory agents were applied in clinical practice. In order to maximize the therapeutic effects and minimize the complications, combination management will be possibly applied by influencing multiple mechanisms.
authors.affiliation: Department of Ophthalmology, Peking University People's Hospital, Beijing, China. zhaomingwei@medmail.com.cn
authors.forename: Ming-Wei
authors.initials: MW
authors.lastname: Zhao
mesh_terms: D020256:Choroidal Neovascularization / Q000188:drug therapy*; D006801:Humans; D010778:Photochemotherapy; D016896:Treatment Outcome